Suppr超能文献

血管性认知障碍:在体外和体内模拟一种关键的神经疾病。

Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo.

作者信息

Helman Alex M, Murphy M Paul

机构信息

Department of Molecular and Cellular Biochemistry, University of Kentucky, 800 South Limestone, Lexington, KY 40536, USA; Sanders-Brown Center on Aging, University of Kentucky, 800 South Limestone, Lexington, KY 40536, USA.

Department of Molecular and Cellular Biochemistry, University of Kentucky, 800 South Limestone, Lexington, KY 40536, USA; Sanders-Brown Center on Aging, University of Kentucky, 800 South Limestone, Lexington, KY 40536, USA.

出版信息

Biochim Biophys Acta. 2016 May;1862(5):975-82. doi: 10.1016/j.bbadis.2015.12.009. Epub 2015 Dec 17.

Abstract

BACKGROUND

Vascular contributions to cognitive impairment and dementia (VCID) is a complex form of dementia, combining aspects of vascular disease and other forms of dementia, such as Alzheimer's disease. VCID encompasses a wide spectrum of cerebrovascular-driven cognitive impairment, from mild cognitive impairment to fully developed dementia. This disease state is further complicated by metabolic disorders, such as type 2 diabetes and hypertension, and lifestyle factors, like obesity and high fat diets.

SCOPE OF REVIEW

This manuscript is meant to both define VCID and review the in vitro and in vivo models of the disease state. This includes in vitro models of the neurovascular unit, models of chronic cerebral hypoperfusion, animals with NOTCH3 mutations as a model of small vessel disease, large animals with cerebral amyloid angiopathy (CAA), and animal models of mixed dementia.

MAJOR CONCLUSIONS

Synthetic microvessels are a promising technique to study the neurovascular unit and canines, despite the cost, are an excellent model to study CAA. While there are several good models of individual aspects of VCID, the heterogeneity of the disease states prevents them from being a model of all aspects of the disease. Therefore, VCID needs to be further defined into disease states that exist within this umbrella term. This includes specific guidelines for stroke counts and stroke locations and further categorization of overlapping cerebrovascular and AD pathologies that contribute to dementia. This will allow for better models and a more thorough understanding of how vascular disease contributes to dementia.

GENERAL SIGNIFICANCE

VCID is the second most common form of dementia and is expected to increase in coming years. The heterogeneity of VCID makes it difficult to study, but without better definitions and models, VCID presents a major public health problem for our aging population. This article is part of a Special Issue entitled: Vascular Contributions to Cognitive Impairment and Dementia, edited by M. Paul Murphy, Roderick A. Corriveau and Donna M. Wilcock.

摘要

背景

血管性认知障碍和痴呆(VCID)是一种复杂的痴呆形式,融合了血管疾病和其他形式痴呆(如阿尔茨海默病)的诸多方面。VCID涵盖了从轻度认知障碍到完全发展的痴呆等广泛的脑血管驱动的认知障碍。这种疾病状态因2型糖尿病和高血压等代谢紊乱以及肥胖和高脂饮食等生活方式因素而进一步复杂化。

综述范围

本手稿旨在定义VCID并综述该疾病状态的体外和体内模型。这包括神经血管单元的体外模型、慢性脑灌注不足模型、NOTCH3突变动物作为小血管疾病模型、患有脑淀粉样血管病(CAA)的大型动物以及混合性痴呆动物模型。

主要结论

合成微血管是研究神经血管单元的一种有前景的技术,犬类尽管成本较高,但却是研究CAA的优秀模型。虽然有几个关于VCID各个方面的良好模型,但疾病状态的异质性使它们无法成为该疾病所有方面的模型。因此,需要将VCID进一步细分为该统称下存在的疾病状态。这包括中风计数和中风部位的具体指南,以及对导致痴呆的重叠脑血管和AD病理学的进一步分类。这将有助于建立更好的模型,并更全面地理解血管疾病如何导致痴呆。

一般意义

VCID是第二常见的痴呆形式,预计在未来几年会增加。VCID的异质性使其难以研究,但如果没有更好的定义和模型,VCID将给我们的老年人口带来重大的公共卫生问题。本文是名为《血管对认知障碍和痴呆的影响》特刊的一部分,由M. Paul Murphy、Roderick A. Corriveau和Donna M. Wilcock编辑。

相似文献

1
Vascular cognitive impairment: Modeling a critical neurologic disease in vitro and in vivo.
Biochim Biophys Acta. 2016 May;1862(5):975-82. doi: 10.1016/j.bbadis.2015.12.009. Epub 2015 Dec 17.
2
Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.
Biochim Biophys Acta. 2016 May;1862(5):887-900. doi: 10.1016/j.bbadis.2015.12.016. Epub 2015 Dec 17.
3
Vascular contributions to cognitive impairment, clinical Alzheimer's disease, and dementia in older persons.
Biochim Biophys Acta. 2016 May;1862(5):878-86. doi: 10.1016/j.bbadis.2015.12.023. Epub 2016 Jan 5.
4
Intracerebral hemorrhage and cognitive impairment.
Biochim Biophys Acta. 2016 May;1862(5):939-44. doi: 10.1016/j.bbadis.2015.12.011. Epub 2015 Dec 12.
5
Clinical-pathologic correlations in vascular cognitive impairment and dementia.
Biochim Biophys Acta. 2016 May;1862(5):945-51. doi: 10.1016/j.bbadis.2015.08.019. Epub 2015 Aug 28.
7
MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
Alzheimers Dement. 2021 Apr;17(4):704-715. doi: 10.1002/alz.12215. Epub 2021 Jan 21.
8
Homocysteine, hyperhomocysteinemia and vascular contributions to cognitive impairment and dementia (VCID).
Biochim Biophys Acta. 2016 May;1862(5):1008-17. doi: 10.1016/j.bbadis.2015.11.015. Epub 2015 Dec 9.
9
Novel imaging techniques in cerebral small vessel diseases and vascular cognitive impairment.
Biochim Biophys Acta. 2016 May;1862(5):926-38. doi: 10.1016/j.bbadis.2015.12.010. Epub 2015 Dec 10.
10
Animal Models of Vascular Cognitive Impairment and Dementia (VCID).
Cell Mol Neurobiol. 2016 Mar;36(2):233-9. doi: 10.1007/s10571-015-0286-3. Epub 2016 Mar 17.

引用本文的文献

1
Soluble epoxide hydrolase inhibition reverses cognitive dysfunction in a mouse model of metabolic syndrome by modulating inflammation.
Prostaglandins Other Lipid Mediat. 2024 Aug;173:106850. doi: 10.1016/j.prostaglandins.2024.106850. Epub 2024 May 10.
3
Multimodality neuroimaging in vascular mild cognitive impairment: A narrative review of current evidence.
Front Aging Neurosci. 2023 Mar 15;15:1073039. doi: 10.3389/fnagi.2023.1073039. eCollection 2023.
4
What type of cell death occurs in chronic cerebral hypoperfusion? A review focusing on pyroptosis and its potential therapeutic implications.
Front Cell Neurosci. 2023 Mar 2;17:1073511. doi: 10.3389/fncel.2023.1073511. eCollection 2023.
5
Plasma biomarkers of vascular dysfunction uniquely relate to a vascular-risk profile of neurocognitive deficits in virally-suppressed adults with HIV.
Brain Behav Immun Health. 2022 Nov 14;26:100560. doi: 10.1016/j.bbih.2022.100560. eCollection 2022 Dec.
6
The Role of the NRF2 Pathway in Maintaining and Improving Cognitive Function.
Biomedicines. 2022 Aug 21;10(8):2043. doi: 10.3390/biomedicines10082043.
8
Advances in Hydrogel-Based Microfluidic Blood-Brain-Barrier Models in Oncology Research.
Pharmaceutics. 2022 May 5;14(5):993. doi: 10.3390/pharmaceutics14050993.
9
3D hydrogel models of the neurovascular unit to investigate blood-brain barrier dysfunction.
Neuronal Signal. 2021 Nov 9;5(4):NS20210027. doi: 10.1042/NS20210027. eCollection 2021 Dec.

本文引用的文献

1
Clearance systems in the brain-implications for Alzheimer disease.
Nat Rev Neurol. 2015 Aug;11(8):457-70. doi: 10.1038/nrneurol.2015.119. Epub 2015 Jul 21.
2
Models and mechanisms of vascular dementia.
Exp Neurol. 2015 Oct;272:97-108. doi: 10.1016/j.expneurol.2015.05.006. Epub 2015 May 15.
3
2015 Alzheimer's disease facts and figures.
Alzheimers Dement. 2015 Mar;11(3):332-84. doi: 10.1016/j.jalz.2015.02.003.
4
Amyloid-β precursor protein: Multiple fragments, numerous transport routes and mechanisms.
Exp Cell Res. 2015 May 15;334(1):45-53. doi: 10.1016/j.yexcr.2014.12.014. Epub 2015 Jan 6.
5
6
From chronic cerebral hypoperfusion to Alzheimer-like brain pathology and neurodegeneration.
Cell Mol Neurobiol. 2015 Jan;35(1):101-10. doi: 10.1007/s10571-014-0127-9. Epub 2014 Oct 29.
7
Hyperhomocysteinemia and neurologic disorders: a review.
J Clin Neurol. 2014 Oct;10(4):281-8. doi: 10.3988/jcn.2014.10.4.281. Epub 2014 Oct 6.
9
Permeability analysis of neuroactive drugs through a dynamic microfluidic in vitro blood-brain barrier model.
Ann Biomed Eng. 2014 Dec;42(12):2379-91. doi: 10.1007/s10439-014-1086-5. Epub 2014 Aug 13.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验